2023
DOI: 10.1080/10406638.2023.2231595
|View full text |Cite
|
Sign up to set email alerts
|

New Inhibitory Effect by Green Synthesized Chalcone Derivatives on the Fungal Deterioration of Archaeological Egyptian Mummy, Egypt

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 57 publications
0
1
0
Order By: Relevance
“…The pharmacophore scaffolds of several compounds are combined to create hybrid molecules. In this regard, anticancer drugs that are safer and more effective than those presently on the market may benefit from hybridization. , In light of these findings, as well as our continuing interest in the synthesis of heterocycles and their bis­(heterocycles), we sought to incorporate N -arylacetamide units into the backbone of thiazole to obtain a novel series of bis-thiazole derivatives linked through biologically active quinoxaline or thienothiophene cores using a “hybrid conjugation of bioactive ligands” approach. Our synthetic strategy employs 2-(4-(1-(2-carbamothioylhydrazineylidene)­ethyl)­phenoxy)- N -(aryl)­acetamides, 2-(4-(2-bromoacetyl)­phenoxy)- N -(aryl)­acetamides, bis­(4,1-phenylene)­bis­(2-bromoethan-1-ones) 7 , bis­(α-bromoketone), and bis­(thiosemicarbazone) as precursors (Figure ).…”
Section: Introductionmentioning
confidence: 99%
“…The pharmacophore scaffolds of several compounds are combined to create hybrid molecules. In this regard, anticancer drugs that are safer and more effective than those presently on the market may benefit from hybridization. , In light of these findings, as well as our continuing interest in the synthesis of heterocycles and their bis­(heterocycles), we sought to incorporate N -arylacetamide units into the backbone of thiazole to obtain a novel series of bis-thiazole derivatives linked through biologically active quinoxaline or thienothiophene cores using a “hybrid conjugation of bioactive ligands” approach. Our synthetic strategy employs 2-(4-(1-(2-carbamothioylhydrazineylidene)­ethyl)­phenoxy)- N -(aryl)­acetamides, 2-(4-(2-bromoacetyl)­phenoxy)- N -(aryl)­acetamides, bis­(4,1-phenylene)­bis­(2-bromoethan-1-ones) 7 , bis­(α-bromoketone), and bis­(thiosemicarbazone) as precursors (Figure ).…”
Section: Introductionmentioning
confidence: 99%